Patented Medicines (Notice of Compliance) Regulations (SOR/93-133)
Full Document:
- HTMLFull Document: Patented Medicines (Notice of Compliance) Regulations (Accessibility Buttons available) |
- XMLFull Document: Patented Medicines (Notice of Compliance) Regulations [86 KB] |
- PDFFull Document: Patented Medicines (Notice of Compliance) Regulations [245 KB]
Regulations are current to 2024-11-26 and last amended on 2017-09-21. Previous Versions
6.07 (1) In an action brought under subsection 6(1), the Federal Court may, on the motion of the second person, declare that a patent or certificate of supplementary protection is ineligible for inclusion on the register.
(2) The Minister may intervene as of right in the motion and make representations and call evidence that are relevant to any issue in the motion or to the factors that the Federal Court is entitled to take into consideration in determining the issue. The Minister may intervene as of right in any appeal arising from the decision made on the motion, whether the Minister intervened at the Federal Court or not.
(3) The Federal Court shall not, in whole or in part, dismiss the action solely on the basis that a patent or certificate of supplementary protection is ineligible for inclusion on the register.
(4) Subsection (1) does not apply in respect of a patent on a patent list that was submitted before June 17, 2006.
- SOR/2017-166, s. 7
- Date modified: